UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168)

Clinical and translational science, 2022-02, Vol.15 (2), p.442-450

2022

Volltextzugriff (PDF)

Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study

Journal of investigative dermatology, 2024-08, Vol.144 (8), p.1762-1771.e6

2024

Volltextzugriff (PDF)

Cardiovascular effects of carbon monoxide and cigarette smoking

Journal of the American College of Cardiology, 2001-11, Vol.38 (6), p.1633-1638

2001

Volltextzugriff (PDF)

Clonidine for smoking cessation

Cochrane database of systematic reviews, 2004-07, Vol.2008 (3), p.CD000058

2004

Volltextzugriff (PDF)

Efficacy of a Bruton's Tyrosine Kinase Inhibitor (PRN‐473) in the treatment of canine pemphigus foliaceus

Veterinary dermatology, 2020-08, Vol.31 (4), p.291-e71

2020

Volltextzugriff (PDF)

Open trial of Bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus

Veterinary dermatology, 2020-10, Vol.31 (5), p.410-e110

2020

Volltextzugriff (PDF)

Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2)

Nicotine & tobacco research, 2002-02, Vol.4 (1), p.101-107

2002

Volltextzugriff (PDF)

Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine

Clinical pharmacology and therapeutics, 2005-03, Vol.77 (3), p.159-169

2005

Volltextzugriff (PDF)

Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy

Journal of the American College of Cardiology, 1997-06, Vol.29 (7), p.1422-1431

1997

Volltextzugriff (PDF)

Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for Acute Myocardial Infarction: Limitation of Myocardial Infarction following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) study

Circulation (New York, N.Y.), 2001-12, Vol.104 (23), p.2778-2783

2001

Volltextzugriff (PDF)

Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine

Clinical pharmacology and therapeutics, 1997-10, Vol.62 (4), p.453-463

1997

Volltextzugriff (PDF)

TIMI Myocardial perfusion grade and ST segment resolution: Association with infarct size as assessed by single photon emission computed tomography imaging

Circulation (New York, N.Y.), 2002-01, Vol.105 (3), p.282-285

2002

Volltextzugriff (PDF)

Impairment of myocardial perfusion in both culprit and nonculprit arteries in acute myocardial infarction: a LIMIT AMI substudy

The American journal of cardiology, 2003-02, Vol.91 (3), p.325-328

2003

Volltextzugriff (PDF)

Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation

BMJ, 1994-10, Vol.309 (6958), p.842-846

International edition, 1994

Volltextzugriff (PDF)

Single lead ST-segment recovery: a simple, reliable measure of successful fibrinolysis after acute myocardial infarction

The American heart journal, 2004-02, Vol.147 (2), p.275-280

2004

Volltextzugriff (PDF)

PRN1008, a Reversible Covalent BTK Inhibitor in Clinical Development for Immune Thrombocytopenic Purpura

Blood, 2017-12, Vol.130, p.1052-1052

2017

Volltextzugriff (PDF)

Open trial of Bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus

Veterinary dermatology, 2020-10, Vol.31 (5), p.410-e110

2020

Volltextzugriff (PDF)

Abstract 2091: PRN1371, an irreversible, covalent inhibitor of FGFR1-4 exhibits sustained pathway inhibition in cancer cell lines

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2091-2091

2017

Volltextzugriff (PDF)

Abstract 1249: PRN1371, an irreversible, covalent inhibitor of FGFR1, 2, 3 and 4 is highly efficacious in preclinical tumor models

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1249-1249

2016

Volltextzugriff (PDF)

Time for contrast material to traverse the epicardial artery and the myocardium in ST-Segment elevation acute myocardial infarction versus unstable angina pectoris/non–ST-elevation acute myocardial infarction

The American journal of cardiology, 2003-05, Vol.91 (10), p.1163-1167

2003

Volltextzugriff (PDF)

Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: Application to smokeless tobacco and nicotine gum

Journal of pharmacokinetics and pharmacodynamics, 2002-08, Vol.29 (4), p.383-402

2002

Volltextzugriff (PDF)

Pharmacokinetics of rhuMAb CD18, a recombinant humanised monoclonal antibody fragment to CD18, in normal healthy human volunteers

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2002, Vol.16 (1), p.63-70

2002

Volltextzugriff (PDF)

Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers

BMJ, 1995-08, Vol.311 (7001), p.363-366

1995

Volltextzugriff (PDF)

Clinical pharmacology of nicotine

Clinics in Dermatology, 1998-09, Vol.16 (5), p.557-564

1998

Volltextzugriff (PDF)

Predictors and timing of adverse experiences during transdermal nicotine therapy

Drug safety, 1999, Vol.20 (6), p.545-555

1999

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(37)
Reviews
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168)

Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study

Cardiovascular effects of carbon monoxide and cigarette smoking

Clonidine for smoking cessation

Efficacy of a Bruton's Tyrosine Kinase Inhibitor (PRN‐473) in the treatment of canine pemphigus foliaceus

Open trial of Bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus

Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2)

Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine

Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy

Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for Acute Myocardial Infarction: Limitation of Myocardial Infarction following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) study

Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine

TIMI Myocardial perfusion grade and ST segment resolution: Association with infarct size as assessed by single photon emission computed tomography imaging

Impairment of myocardial perfusion in both culprit and nonculprit arteries in acute myocardial infarction: a LIMIT AMI substudy

Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation

Single lead ST-segment recovery: a simple, reliable measure of successful fibrinolysis after acute myocardial infarction

PRN1008, a Reversible Covalent BTK Inhibitor in Clinical Development for Immune Thrombocytopenic Purpura

Open trial of Bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus

Abstract 2091: PRN1371, an irreversible, covalent inhibitor of FGFR1-4 exhibits sustained pathway inhibition in cancer cell lines

Abstract 1249: PRN1371, an irreversible, covalent inhibitor of FGFR1, 2, 3 and 4 is highly efficacious in preclinical tumor models

Time for contrast material to traverse the epicardial artery and the myocardium in ST-Segment elevation acute myocardial infarction versus unstable angina pectoris/non–ST-elevation acute myocardial infarction

Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: Application to smokeless tobacco and nicotine gum

Pharmacokinetics of rhuMAb CD18, a recombinant humanised monoclonal antibody fragment to CD18, in normal healthy human volunteers

Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers

Clinical pharmacology of nicotine

Predictors and timing of adverse experiences during transdermal nicotine therapy

Suchergebnisse filtern